CD4 and herpes zoster: Additionally, TO modulates IFN-γ and CD4+ cells in herpes-zoster patients and improves the survival of septic pediatric patients by modulating C-reactive protein (CRP) and lymphocyte and neutrophil counts (Castrejón Vázquez et al., 2019; Estrada-Parra et al., 1998).